• Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Innovation Watch
    Feb. 02, 2026

    AI-powered decision intelligence marks a pivotal shift in enterprise architecture, moving beyond traditional analytics and Business Intelligence (BI) tools toward systems that can simulate, optimize, and operationalize decisions in near real time. These solutions enable enterprises…